| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-12 |
| mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
6e-10 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-10 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-09 |
| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
9e-09 |
| mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-07 |